Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).
Ginsburg, O. et al. The role of genomics in global cancer prevention. Nat. Rev. Clin. Oncol. 18, 116–128 (2021).
Gotay, C., Dummer, T. & Spinelli, J. Cancer risk: prevention is crucial. Science 347, 728 (2015).
Article PubMed CAS Google Scholar
Page, I. H. Low cholesterol–low fat diets in prevention and treatment of atherosclerosis. Med. Clin. North Am. 36, 195–199 (1952).
Article PubMed CAS Google Scholar
Serrano, D., Lazzeroni, M. & Bonanni, B. Cancer chemoprevention: much has been done, but there is still much to do. State of the art and possible new approaches. Mol. Oncol. 9, 1008–1017 (2015).
Meyskens, F. L., Jr. et al. Cancer Prevention: obstacles, challenges and the road ahead. J. Natl. Cancer Inst. 108, djv309 (2016).
Penny, L. K. & Wallace, H. M. The challenges for cancer chemoprevention. Chem. Soc. Rev. 44, 8836–8847 (2015).
Article PubMed CAS Google Scholar
Menter, D. G. & Bresalier, R. S. An Aspirin a day: new pharmacological developments and cancer chemoprevention. Annu. Rev. Pharm. Toxicol. 63, 165–186 (2023).
Patra, S. et al. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics. Semin. Cancer Biol. 73, 310–320 (2021).
Article PubMed CAS Google Scholar
Cai, H. et al. Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci. Transl. Med. 7, 298ra117 (2015).
Article PubMed PubMed Central Google Scholar
William, W. N. Jr., Heymach, J. V., Kim, E. S. & Lippman, S. M. Molecular targets for cancer chemoprevention. Nat. Rev. Drug Discov. 8, 213–225 (2009).
Article PubMed CAS Google Scholar
Baena Ruiz, R. & Salinas Hernandez, P. Cancer chemoprevention by dietary phytochemicals: epidemiological evidence. Maturitas 94, 13–19 (2016).
Article PubMed CAS Google Scholar
Dunn, B. K. & Kramer, B. S. Cancer prevention: lessons learned and future directions. Trends Cancer 2, 713–722 (2016).
Article PubMed PubMed Central Google Scholar
Maresso, K. C. et al. Molecular cancer prevention: current status and future directions. CA Cancer J. Clin. 65, 345–383 (2015).
Article PubMed PubMed Central Google Scholar
Reynolds, A. R. et al. A view on drug development for cancer prevention. Cancer Discov. 13, 1058–1083 (2023).
Article PubMed CAS Google Scholar
Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 83, 770–803 (2020).
Article PubMed CAS Google Scholar
Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3, 768–780 (2003).
Article PubMed CAS Google Scholar
Amin, A. R., Kucuk, O., Khuri, F. R. & Shin, D. M. Perspectives for cancer prevention with natural compounds. J. Clin. Oncol. 27, 2712–2725 (2009).
Article PubMed PubMed Central Google Scholar
Katz, L. & Baltz, R. H. Natural product discovery: past, present, and future. J. Ind. Microbiol. Biotechnol. 43, 155–176 (2016).
Article PubMed CAS Google Scholar
G, M. S. et al. Cancer chemoprevention: a strategic approach using phytochemicals. Front. Pharm. 12, 809308 (2021).
Shu, L. et al. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev. 29, 483–502 (2010).
Article PubMed CAS Google Scholar
Russo, G. L., Spagnuolo, C. & Russo, M. Reassessing the role of phytochemicals in cancer chemoprevention. Biochem. Pharmacol. 228, 116165 (2024).
Article PubMed CAS Google Scholar
Mize, B. K. et al. Discovery and development of botanical natural products and their analogues as therapeutics for ovarian cancer. Nat. Prod. Rep. 40, 1250–1270 (2023).
Article PubMed PubMed Central CAS Google Scholar
Mignani, S. et al. Dendrimers in combination with natural products and analogues as anti-cancer agents. Chem. Soc. Rev. 47, 514–532 (2018).
Article PubMed CAS Google Scholar
Fisher, B. et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 90, 1371–1388 (1998).
Article PubMed CAS Google Scholar
Cuzick, J. et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 361, 296–300 (2003).
Article PubMed CAS Google Scholar
Cuzick, J. et al. Long-term results of tamoxifen prophylaxis for breast cancer–96-month follow-up of the randomized IBIS-I trial. J. Natl. Cancer Inst. 99, 272–282 (2007).
Article PubMed CAS Google Scholar
Vogel, V. G. et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: preventing breast cancer. Cancer Prev. Res. 3, 696–706 (2010).
Moen, M. D. & Keating, G. M. Raloxifene: a review of its use in the prevention of invasive breast cancer. Drugs 68, 2059–2083 (2008).
Article PubMed CAS Google Scholar
Goss, P. E. et al. Exemestane for breast-cancer prevention in postmenopausal women. New Engl. J. Med. 364, 2381–2391 (2011).
Article PubMed CAS Google Scholar
Cuzick, J. et al. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial. Lancet 395, 117–122 (2020).
Article PubMed PubMed Central CAS Google Scholar
Patterson, S. L., Colbert Maresso, K. & Hawk, E. Cancer chemoprevention: successes and failures. Clin. Chem. 59, 94–101 (2013).
Article PubMed CAS Google Scholar
Lebwohl, M. et al. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. JAMA Dermatol. 149, 666–670 (2013).
Article PubMed CAS Google Scholar
Martin, G. & Swanson, N. Clinical findings using ingenol mebutate gel to treat actinic keratoses. J. Am. Acad. Dermatol. 68, S39–S48 (2013).
Comments (0)